The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the DIAL study (NCI 10089), a randomized phase 2 trial of varlilumab combined with nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (r/r B-NHL).
 
Jose Caetano Villasboas
Consulting or Advisory Role - Curio Science (Inst); Kite/Gilead (Inst); Regeneron (Inst); TG Therapeutics (Inst)
Research Funding - Aptose Biosciences (Inst); Enterome (Inst); Epizyme (Inst); Regeneron (Inst)
 
Justin Paul Kline
Honoraria - Curio Science
Consulting or Advisory Role - Daiichi Sankyo Nordics; Gilead Sciences; Karyopharm Therapeutics; Merck
Speakers' Bureau - Kite/Gilead
Research Funding - Merck; verastem
 
Aleksandr Lazaryan
Stock and Other Ownership Interests - Abbvie; Amgen; Amwise; Bristol-Myers Squibb; Crispr Therapeutics; Merck; Pfizer; Teladoc; Thermo Fisher Scientific
Consulting or Advisory Role - Avrobio (Inst); Humanigen (Inst); Kadmon (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - Acerta Pharma; ADC Therapeutics; BTG; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Francisco J. Hernandez-Ilizaliturri
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Kite/Gilead; Novartis; Pharmacyclics; Seagen; Takeda
 
Farrukh Tauseef Awan
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Celgene; Clinical Care Options; DAVA Pharmaceuticals; Genentech; Gilead Sciences; Janssen Oncology; Karyopharm Therapeutics; Medscape; MEI Pharma; Novartis; Pharmacyclics; Sunesis Pharmaceuticals; Verastem
Speakers' Bureau - Abbvie; AstraZeneca
Research Funding - Innate Pharma; Pharmacyclics
 
Praveen Ramakrishnan Geethakumari
No Relationships to Disclose
 
Reem Karmali
Honoraria - Bio Ascend; Prime Oncology
Consulting or Advisory Role - EUSA Pharma; Genentech/Roche; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; Morphosys
Speakers' Bureau - AstraZeneca; BeiGene; Kite/Gilead; MorphoSys/Incyte
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Juno Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Prime Oncology
 
Leyla Shune
No Relationships to Disclose
 
Frederick Lansigan
Consulting or Advisory Role - Celgene
 
Craig B. Reeder
Research Funding - BeiGene (Inst); Bristol Hospice (Inst); Celgene (Inst); Janssen (Inst); Millennium (Inst); Prothena (Inst)
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Genentech/Roche; Janssen; Merck; MorphoSys; Seagen
Research Funding - Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); LAM Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Millennium (Inst); Roche/Genentech (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
Expert Testimony - Jim Harmon
 
Elad Sharon
No Relationships to Disclose
 
Pamela J. Atherton
No Relationships to Disclose
 
Jack Fiskum
No Relationships to Disclose
 
Jun Yin
Employment - Mayo Clinic
 
Alex A. Adjei
Research Funding - Bayer Schering Pharma (Inst); I-Mab (Inst); Jacobio (Inst); Kura Oncology (Inst); Merck KGaA (Inst); Tesaro (Inst); Zai Lab (Inst)
(OPTIONAL) Uncompensated Relationships - Merck KGaA; Swiss Rockets; Zai Lab
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)